20
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Increased circulating endothelins are not of cardiopulmonary origin in heart failure patients

, , , &
Pages 341-347 | Received 19 Jul 2004, Accepted 09 Feb 2005, Published online: 08 Jul 2009

References

  • Pacher R, Bergler-Klein J, Globits S, Teufelsbauer H, Schuller M, Krauter A, et al. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. Am J Cardiol 1993;71:1293–9.
  • Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, et al. Endothelin in human congestive heart failure. Circulation 1994;89:1580–6.
  • Galatius S, Wroblewski H, Sorensen VB, Bie P, Parving HH, Kastrup J. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation? Am Heart J 1999;137:549–54.
  • Galatius-Jensen S, Wroblewski H, Emmeluth C, Bie P, Haunso S, Kastrup J. Plasma endothelin in congestive heart failure: a predictor of cardiac death? J Card Fail 1996;2:71–6.
  • Selvais PL, Robert A, Ahn S, van Linden F, Ketelslegers JM, Pouleur H, et al. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Failure 2000;6: 201–7.
  • Fukuchi M, Giaid A. Expression of endothelin-1 and endothelin-converting enzyme-1 mRNAs and proteins in failing human hearts. J Cardiovasc Pharmacol 1998;31 Suppl 1:S421–3.
  • Suzuki T, Kumazaki T, Mitsui Y. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 1993;191: 823–30.
  • Thomas PB, Liu EC, Webb ML, Mukherjee R, Hebbar L, Spinale FG. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol 1996;271:H2629—H37.
  • Aiello EA, Villa-Abrille MC, Cingolani HE. Autocrine stimulation of cardiac Na(+)-Ca(2+) exchanger currents by endogenous endothelin released by angiotensin II. Circ Res 2002;90:374–6.
  • Dupuis J, Stewart DJ, Cernacek P, Gosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 1996;94:1578–84.
  • Kruger D, Sheikhzadeh A, Giannitsis E, Stierle U. Cardiac release and kinetics of endothelin after severe short-lasting myocardial ischemia. J Am Coll Cardiol 1997;30:942–6.
  • Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995;92:2426–31.
  • Hasdai D, Holmes DR Jr, Garratt KN, Edwards WD, Lerman A. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation 1997;95:357–62.
  • Tsutamoto T, Wada A, Hisanaga T, Maeda K, Ohnishi M, Mabuchi N, et al. Relationship between endothelin-1 extraction in the peripheral circulation and systemic vascular resistance in patients with severe congestive heart failure. J Am Coll Cardiol 1999;33:530–7.
  • Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353–5.
  • Stangl K, Dschietzig T, Richter C, Laule M, Stangl V, Tanis E, et al. Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy. Circulation 2000;102:1132–8.
  • Staniloae C, Dupuis J, White M, Gosselin G, Dyrda I, Bois M, et al. Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension. J Card Fail 2004;10:427–32.
  • Parker JD, Thiessen JJ. Increased endothelin-1 production in patients with chronic heart failure. Am J Physiol Heart Circ Physiol 2004;286:H1141—H5.
  • Galatius-Jensen S, Wroblewski H, Emmeluth C, Bie P, Haunso S, Kastrup J. Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril. Cardiovasc Res 1996;32:1148–54.
  • Grenier O, Pousset F, Isnard R, Kalotka H, Carayon A, Maistre G, et al. Captopril does not acutely modulate plasma endothelin-1 concentration in human congestive heart failure. Cardiovasc Drugs Ther 1996;10:561–5.
  • Townend J, Doran J, Jones S, Davies M. Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure. Int J Cardiol 1994;43:299–304.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.